| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001556408 |
| P356 | DOI | 10.1186/1742-4690-8-67 |
| P932 | PMC publication ID | 3189118 |
| P698 | PubMed publication ID | 21843318 |
| P5875 | ResearchGate publication ID | 51573046 |
| P50 | author | Katherine Luzuriaga | Q15877364 |
| Michael Kishko | Q94482488 | ||
| Mohan Somasundaran | Q123576137 | ||
| Paul R Clapham | Q123576143 | ||
| P2093 | author name string | Frank Brewster | |
| John L Sullivan | |||
| P2860 | cites work | Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 |
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors | Q24655129 | ||
| The neighbor-joining method: a new method for reconstructing phylogenetic trees | Q25939010 | ||
| A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences | Q27860580 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Q29619254 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. | Q29622903 | ||
| Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene | Q33195147 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants | Q33533351 | ||
| 4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms | Q33547451 | ||
| Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry | Q33769382 | ||
| Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels | Q33780649 | ||
| HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry | Q33807529 | ||
| Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum | Q33850575 | ||
| Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines | Q33911935 | ||
| Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant | Q34301874 | ||
| The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. | Q34341843 | ||
| Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 | ||
| Pediatric HIV-1 infection: advances and remaining challenges | Q34630043 | ||
| Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants | Q34717113 | ||
| Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. | Q34717126 | ||
| Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretro | Q34992440 | ||
| Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease | Q35127401 | ||
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa | Q35140032 | ||
| Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry | Q35784750 | ||
| Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission | Q35832182 | ||
| Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. | Q35933967 | ||
| The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus | Q36033283 | ||
| HIV/AIDS in women: an expanding epidemic | Q36157693 | ||
| Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages | Q36340560 | ||
| 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response | Q36483956 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection | Q36647820 | ||
| Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues | Q37015492 | ||
| Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission | Q37022605 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. | Q37275049 | ||
| Viral characteristics of transmitted HIV. | Q37447478 | ||
| Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations | Q37630336 | ||
| Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh | Q39351562 | ||
| Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population | Q39439717 | ||
| Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 | Q39612212 | ||
| T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. | Q40456521 | ||
| Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns | Q41757554 | ||
| Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways | Q44249579 | ||
| Mother-to-child transmission of HIV: a global perspective | Q45200255 | ||
| CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site | Q45419807 | ||
| Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection | Q45848225 | ||
| Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants | Q45867857 | ||
| Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype | Q71599825 | ||
| Mother-to-child transmission of HIV-1: the 'all mucosal' hypothesis as a predominant mechanism of transmission | Q77974211 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 67 | |
| P577 | publication date | 2011-08-15 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Genotypic and functional properties of early infant HIV-1 envelopes | |
| P478 | volume | 8 |
| Q38926812 | Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cells |
| Q98906656 | Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection |
| Q33879282 | Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally. |
| Q39314021 | Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism |
| Q39400706 | Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties |
| Q35143626 | Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model |
| Q34853667 | HIV-1 autologous antibody neutralization associates with mother to child transmission |
| Q35216488 | HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages |
| Q35996364 | Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. |
| Q52577900 | Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. |
| Q35694015 | Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. |
| Q40331385 | Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk |
| Q90204238 | Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants |
| Q36246315 | Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope |
| Q38851899 | Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1-Exposed Ugandan Infants |
| Q36694846 | Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates |
| Q36588632 | Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants |
| Q36286175 | Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission |
| Q36634965 | Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes |
| Q36276632 | The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1 |
| Q37365618 | The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context? |
| Q35593158 | Viral determinants of HIV-1 macrophage tropism |
| Q35633017 | Viremic relapse after HIV-1 remission in a perinatally infected child |
Search more.